{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T11:40:34Z","timestamp":1782819634916,"version":"3.54.5"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Jiangsu Pharmaceutical Association Hospital Pharmacy Research Project","award":["H202109"],"award-info":[{"award-number":["H202109"]}]},{"name":"Jiangsu Pharmaceutical Association Hospital Pharmacy Research Project","award":["H202334"],"award-info":[{"award-number":["H202334"]}]},{"name":"Jiangsu Research Hospital Association for Precision Medication","award":["JY202203"],"award-info":[{"award-number":["JY202203"]}]},{"name":"Gusu School Nanjing Medical University","award":["GSKY20240207"],"award-info":[{"award-number":["GSKY20240207"]}]},{"name":"Gusu Talent Program","award":["GSWS2022069"],"award-info":[{"award-number":["GSWS2022069"]}]},{"name":"Clinical Research Fund of Nanjing Medical University","award":["2024KF0237"],"award-info":[{"award-number":["2024KF0237"]}]},{"name":"Clinical Research Fund of Nanjing Medical University","award":["2024KF0256"],"award-info":[{"award-number":["2024KF0256"]}]},{"name":"China Medical and Health Development Foundation","award":["202427"],"award-info":[{"award-number":["202427"]}]},{"name":"Suzhou Pharmaceutical Association Hospital Pharmacy Research Project","award":["Syhky202313"],"award-info":[{"award-number":["Syhky202313"]}]},{"name":"Suzhou Pharmaceutical Association Hospital Pharmacy Research Project","award":["Syhky202312"],"award-info":[{"award-number":["Syhky202312"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s11095-025-03958-5","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T23:39:45Z","timestamp":1762299585000},"page":"1993-2005","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Population Pharmacokinetics of Intravenous Levetiracetam in Neurosurgical Patients: Dosage Optimization Based on CrCl and Mannitol Use"],"prefix":"10.1007","volume":"42","author":[{"given":"Jinwei","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianglong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunmeng","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenjia","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanzhen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongtong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxia","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhong","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mian","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"issue":"1","key":"3958_CR1","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/CCM.0000000000006065","volume":"52","author":"E Valdes","year":"2024","unstructured":"Valdes E, Fang T, Boffa M, Frontera JA. Optimal dosing of levetiracetam for seizure prophylaxis in critically ill patients: a prospective observational study. Crit Care Med. 2024;52(1):e1\u201310.","journal-title":"Crit Care Med"},{"key":"3958_CR2","doi-asserted-by":"publisher","DOI":"10.1177\/17562864221114357","volume":"15","author":"S Liang","year":"2022","unstructured":"Liang S, Fan X, Chen F, Liu Y, Qiu B, Zhang K, et al. Chinese guideline on the application of anti-seizure medications in the perioperative period of supratentorial craniocerebral surgery. Ther Adv Neurol Disord. 2022;15:17562864221114357.","journal-title":"Ther Adv Neurol Disord"},{"issue":"1","key":"3958_CR3","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1007\/s12028-021-01296-z","volume":"36","author":"T Fang","year":"2022","unstructured":"Fang T, Valdes E, Frontera JA. Levetiracetam for seizure prophylaxis in neurocritical care: a systematic review and meta-analysis. Neurocrit Care. 2022;36(1):248\u201358.","journal-title":"Neurocrit Care"},{"key":"3958_CR4","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3389\/fneur.2013.00192","volume":"4","author":"C Wright","year":"2013","unstructured":"Wright C, Downing J, Mungall D, Khan O, Williams A, Fonkem E, et al. Clinical pharmacology and pharmacokinetics of levetiracetam. Front Neurol. 2013;4:192.","journal-title":"Front Neurol"},{"issue":"8","key":"3958_CR5","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1111\/epi.16961","volume":"62","author":"JT Haller","year":"2021","unstructured":"Haller JT, Bonnin S, Radosevich J. Rapid administration of undiluted intravenous levetiracetam. Epilepsia. 2021;62(8):1865\u201370.","journal-title":"Epilepsia"},{"issue":"1","key":"3958_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s40264-021-01122-7","volume":"45","author":"A Alkazemi","year":"2022","unstructured":"Alkazemi A, McLaughlin KC, Chan MG, Schontz MJ, Anger KE, Szumita PM. Safety of intravenous push Levetiracetam compared to intravenous piggyback at a tertiary academic medical center: a retrospective analysis. Drug Saf. 2022;45(1):19\u201326.","journal-title":"Drug Saf"},{"issue":"8","key":"3958_CR7","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s40261-015-0303-9","volume":"35","author":"N Toublanc","year":"2015","unstructured":"Toublanc N, Du X, Liu Y, Chen Q, Singh P, Chan R, et al. Pharmacokinetics, safety and bioequivalence of levetiracetam intravenous infusion and oral tablets in healthy Chinese subjects. Clin Drug Investig. 2015;35(8):495\u2013503.","journal-title":"Clin Drug Investig"},{"issue":"7","key":"3958_CR8","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1177\/10600280231202246","volume":"58","author":"SS Harlan","year":"2024","unstructured":"Harlan SS, Philpott CD, Keegan SP, Droege ME, Karve AS, Foreman B, et al. Pharmacokinetics of levetiracetam seizure prophylaxis in severe traumatic brain injury. Ann Pharmacother. 2024;58(7):705\u201314.","journal-title":"Ann Pharmacother"},{"issue":"10","key":"3958_CR9","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1592\/phco.31.10.934","volume":"31","author":"DD Spencer","year":"2011","unstructured":"Spencer DD, Jacobi J, Juenke JM, Fleck JD, Kays MB. Steady-state pharmacokinetics of intravenous levetiracetam in neurocritical care patients. Pharmacotherapy. 2011;31(10):934\u201341.","journal-title":"Pharmacotherapy"},{"key":"3958_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13101690","author":"I Bilbao-Meseguer","year":"2021","unstructured":"Bilbao-Meseguer I, Barrasa H, As\u00edn-Prieto E, Alarcia-Lacalle A, Rodr\u00edguez-Gasc\u00f3n A, Maynar J, et al. Population pharmacokinetics of levetiracetam and dosing evaluation in critically ill patients with normal or augmented renal function. Pharmaceutics. 2021. https:\/\/doi.org\/10.3390\/pharmaceutics13101690.","journal-title":"Pharmaceutics"},{"issue":"5","key":"3958_CR11","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s40262-020-00979-8","volume":"60","author":"FB Sime","year":"2021","unstructured":"Sime FB, Roberts JA, Jeffree RL, Pandey S, Adiraju S, Livermore A, et al. Population pharmacokinetics of levetiracetam in patients with traumatic brain injury and subarachnoid hemorrhage exhibiting augmented renal clearance. Clin Pharmacokinet. 2021;60(5):655\u201364.","journal-title":"Clin Pharmacokinet"},{"key":"3958_CR12","unstructured":"World Health Organization Uppsala Monitoring Centre (WHO-UMC). The use of the WHO-UMC system for standardised case causality assessment. Available at: https:\/\/www.who.int\/publications\/m\/item\/WHO-causality-assessment. Accessed June 2, 2024"},{"issue":"5","key":"3958_CR13","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1213\/ANE.0000000000002864","volume":"126","author":"P Schober","year":"2018","unstructured":"Schober P, Boer C, Schwarte LA. Correlation coefficients: appropriate use and interpretation. Anesth Analg. 2018;126(5):1763\u20138.","journal-title":"Anesth Analg"},{"key":"3958_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00826","author":"C Lv","year":"2017","unstructured":"Lv C, Liu C, Yao Z, Gao X, Sun L, Liu J, et al. The clinical pharmacokinetics and pharmacodynamics of warfarin when combined with compound danshen: a case study for combined treatment of coronary heart diseases with atrial fibrillation. Front Pharmacol. 2017. https:\/\/doi.org\/10.3389\/fphar.2017.00826.","journal-title":"Front Pharmacol"},{"issue":"3","key":"3958_CR15","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1111\/bcp.15572","volume":"89","author":"Y Li","year":"2023","unstructured":"Li Y, Wang ML, Guo Y, Cao YF, Zhao MM, Zhao LM. Population pharmacokinetics and dosing regimen optimization of levetiracetam in epilepsy during pregnancy. Br J Clin Pharmacol. 2023;89(3):1152\u201361.","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"3958_CR16","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1016\/j.xphs.2020.02.018","volume":"109","author":"MP Hern\u00e1ndez-Mitre","year":"2020","unstructured":"Hern\u00e1ndez-Mitre MP, Medell\u00edn-Garibay SE, Rodr\u00edguez-Leyva I, Rodr\u00edguez-Pinal CJ, Zaraz\u00faa S, Jung-Cook HH, et al. Population pharmacokinetics and dosing recommendations of levetiracetam in adult and elderly patients with epilepsy. J Pharm Sci. 2020;109(6):2070\u20138.","journal-title":"J Pharm Sci"},{"issue":"3","key":"3958_CR17","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s40262-020-00963-2","volume":"60","author":"ZR Li","year":"2021","unstructured":"Li ZR, Wang CY, Zhu X, Jiao Z. Population pharmacokinetics of Levetiracetam: a systematic review. Clin Pharmacokinet. 2021;60(3):305\u201318.","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"3958_CR18","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2133\/dmpk.DMPK-13-RG-045","volume":"29","author":"N Toublanc","year":"2014","unstructured":"Toublanc N, Lacroix BD, Yamamoto J. Development of an integrated population pharmacokinetic model for oral levetiracetam in populations of various ages and ethnicities. Drug Metab Pharmacokinet. 2014;29(1):61\u20138.","journal-title":"Drug Metab Pharmacokinet"},{"issue":"9","key":"3958_CR19","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1080\/00498254.2020.1746981","volume":"50","author":"E Karatza","year":"2020","unstructured":"Karatza E, Markantonis SL, Savvidou A, Verentzioti A, Siatouni A, Alexoudi A, et al. Pharmacokinetic and pharmacodynamic modeling of levetiracetam: investigation of factors affecting the clinical outcome. Xenobiotica. 2020;50(9):1090\u2013100.","journal-title":"Xenobiotica"},{"issue":"2","key":"3958_CR20","doi-asserted-by":"publisher","DOI":"10.1111\/fcp.13059","volume":"39","author":"A Chykharivska","year":"2025","unstructured":"Chykharivska A, Kagan L, Wagner M, Brunetti L. Real-world interpatient variability in the pharmacokinetics of levetiracetam. Fundam Clin Pharmacol. 2025;39(2):e13059.","journal-title":"Fundam Clin Pharmacol"},{"issue":"2","key":"3958_CR21","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1089\/jpm.2019.0525","volume":"24","author":"P Papa","year":"2021","unstructured":"Papa P, Oricchio F, Gin\u00e9s M, Maldonado C, Tashjian A, Ibarra M, et al. Pharmacokinetics of subcutaneous levetiracetam in palliative care patients. J Palliat Med. 2021;24(2):248\u201351.","journal-title":"J Palliat Med"},{"key":"3958_CR22","unstructured":"Food and Drug Administration(FDA). Utilize the FDA website to search for the drug information leaflet of levetiracetam and the latest supplementary documents. Available at: https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=overview.process&ApplNo=021872. Accessed August 20, 2025"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-025-03958-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-025-03958-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-025-03958-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T14:35:18Z","timestamp":1765463718000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-025-03958-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":22,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["3958"],"URL":"https:\/\/doi.org\/10.1007\/s11095-025-03958-5","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"12 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influ ence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}